17 results found | searching for "Myers"

1 2 Next Last 
  • fmbfishingcharter
  • Food Fishing Spots in Fort Myers Catch your dinner at the top food fishing spots in Fort Myers. These productive waters are known for delicious fish like snapper and sheepshead, making your day both fun and flavorful. Always Fun Charters LLC knows the spots where great meals begin. Plan your catch-and-cook adventure with us today! Visit US:- https://fmbfishingcharter.com/
    by fmbfishingcharter,  Small Business 
    0 reply
  • lihongwan9
  • HPMC Coating Powder for GastericTablets DMF Our History ILE was founded in 1996 as a manufacturer of advanced polymeric film coating systems, with the capability to provide technical support for the formulation of pharmaceutical dosage forms in the China Market. In 2016, Also established Medieye Holding company to cover the business of global procurement and overseas sales. Our Factory ILE is located in the Chinese city of Tianjin as a global supplier of coating materials. China's first independent research and development, production, and marketing suppliers are film coating agents. Controlled manufacturing area in compliance with cGMP: 1000 m2 Cleanroom classification: 100,000 Capacity: 600,000 kg/year Our Product Film Coatings-EASPRAY, Film Coatings-EASTROL, Film Coatings-EASCOL, Food&Feed Additives, Excipients, Food&Feed Additives, Excipients Product Application Coating materials are widely used in tablets, granules, Solid dosage forms, and so on. Our Certificate In the Year 2000, ILE company passed the authentication of Tianjin high-tech enterprises In the Year 2004, the "film coating agent insoluble pigment processing methods" won the national invention patent In the Year 2006, Obtained ISO9001: 2000 certificate issued by the French International Quality Certification Ltd (BVQI) In the Year 2007, get SFDA issued 鈥淓thylcellulose Aqueous Dispersion 鈥漝rug registration certificate锛?Approval code: Chinese medicine F20070001 In the Year 2010, 鈥淔ishing enteric oral vaccines and its preparation method鈥濓紝 won the national invention patent In the year 2012, ILE's Environmental protection Film Coating Materials approved as Tianjin Innovation Fund Project from the Ministry of Science and The technology of China; In the year 2012, ILE's film coating products get DMF from US FDA; Until the year 2012, ILE already passed the audit by multinational companies, such as Pfizer-Wyeth, GSK, ISP, Ashland, Bristol-Myers Squibb. In the year 2012, ILE enter into Pfizer-Wyeth global supplier list Production Equipment By GMP standard management, the most advanced international High-speed powder dispersing equipment. The most advanced international color matching system, to control the production process on-line Production Market built commercial partnerships in the pharmaceutical and chemical industries in the United States, Germany, Italy, Southeast Asia, South America, South Africa, the Middle East, and other countries and areas throughout the world. Our service Technical Center 鈥?Customized Services to meet customers鈥?requests Formula Design Color Design Core tablet Design Special tablet Design for Herbal Medicine Coating technology training Logistics center (1) 600 m2 storage space (2) Design storage capacity of 100T (3) Importer, exporter of goods (4) Logistics plan (5) Storage and transportation (6)Raw materials procurement Build a strong technical team, and take "Technical Services" as our core competitiveness. The number of experts in film coating technology For many years, experts in the field of solid dosage have been involved. Professional quality inspection staff and laboratory personnel. Cooperative relations with the Tianjin Institute of Pharmaceutical Research, the College of Pharmacy, and domestic research institutions were established.HPMC Coating Powder for GastericTablets DMF website:http://www.ile-filmcoating.com/
    by lihongwan9,  Poetry 
    0 reply
  • icecricnews
  • Eliminator Match 72 LSG vs MI Highlights and Match Report: In a thrilling encounter, the Mumbai Indians emerged victorious against the Lucknow Super Giants by a comprehensive margin of 81 runs in the Eliminator match of the TATA IPL 2023. Visit- https://www.icecric.news/match-72-lsg-vs-mi-highlights-and-match-report/ #LucknowSuperGiantsvsMumbai #LSGvsMI #MatchReport #LSG #MI #LucknowSuperGiants #MumbaiIndians #Dream11 #ViratKohli #Dhoni #RohitSharma #Jersey #WIvsIND #WWERaw #Jadeja #Sami #Myers #Alcaraz #RandyArozarena #wimbledon2023 #AdleyRutschman #HomeRunDerby #Northwestern #Finn #JulioRodriguez #Melo #Imperium #Rhea #Ciampa #Seattle #Ricochet #PeteAlonso #Sports #News #icecricnews #Cricket
    by icecricnews,  News & Events 
    0 reply
  • icecricnews
  • TATA IPL 2023 Final Highlights Match Report: Ravindra Jadeja’s heroics propel the Chennai Super Kings to their fifth IPL title. Visit- https://www.icecric.news/csk-vs-gt-ipl-2023-final-highlights-match-report/ #TATAIPL #IPLFinal2023 #CSKvsGT #CSKvsGTMatchReport #FinalHighlights #CSK #GT #ChennaiSuperKings #GujaratTitans #Dream11 #ViratKohli #Dhoni #RohitSharma #Jersey #WIvsIND #WWERaw #Jadeja #Sami #Myers #Alcaraz #RandyArozarena #wimbledon2023 #AdleyRutschman #HomeRunDerby #Northwestern #Finn #JulioRodriguez #Melo #Imperium #Rhea #Ciampa #Seattle #Ricochet #PeteAlonso #Sports #News #icecricnews #Cricket
    by icecricnews,  Sports 
    0 reply
  • jameshebrew
  • CAR-T Cell Therapy market Professional Survey Report by 2035 As the six approved CAR-T cell therapies, including Breyanzi®, Abecma™ and CARVYKTI™ are poised to achieve blockbuster status, along with a promising development pipeline, the field of CAR-T cell therapies has gained significant traction Roots Analysis is pleased to announce the publication of its recent study, titled, “Global CAR-T Cell Therapy Market (4th Edition), 2022-2035.” The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:  A detailed assessment of the current market landscape of CAR-T-cell therapies.  An analysis of key insights derived from the study featuring a competitive analysis, highlighting the popular target antigens related to hematological malignancies and solid tumors.  A detailed analysis of completed, ongoing and planned clinical studies related to CAR-T cell therapies.  An insightful analysis highlighting the key opinion leaders (KOLs) in this domain featuring an analysis of the various principal investigators of clinical trials related to CAR-T cell therapies.  Elaborate profiles of marketed and mid- to late-stage clinical products (phase I/II or above).  An analysis of various type of partnership that have been inked between several stakeholders in the domain of CAR-T-cell therapies.  An analysis of the investments that have been made into companies that have proprietary CAR-T cell-based products / technologies.  An in-depth analysis of patents related to CAR-T cell therapies, filed / granted till 2022.  A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.  An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies.  A review of the key promotional strategies being adopted by the developers of the approved CAR-T cell therapies.  Elaborate profiles of the several leading players in the domain of CAR-T cell therapies. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Target Indication(s)  Non-Hodgkin’s Lymphoma  Multiple Myeloma  Acute Lymphoblastic Leukemia  Chronic Lymphocytic Leukemia  Hodgkin’s Lymphoma  Acute Myeloid Leukemia  Ovarian Cancer  Generalized Myasthenia Gravis (MG)  Renal Cell Carcinoma  Target Antigen  CD19  BCMA  CD19/22  Others  Key Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa  Rest of the World Transcripts of interviews held with the following senior level representatives of stakeholder companies:  Troels Jordansen (Chief Executive Officer, Glycostem Therapeutics)  Wei (William) Cao (Chief Executive Officer, Gracell Biotechnologies)  Miguel Forte (Chief Operating Officer, TxCell)  Adrian Bot (Vice President, Scientific Affairs, Kite Pharma)  Vincent Brichard (Vice President, Immuno-Oncology, Celyad)  Brian Dattilo (Manager of Business Development, Waisman Biomanufacturing)  Aino Kalervo (Former Competitive Intelligence Manager, Strategy & Business Development, Theravectys)  Xian-Bao Zhan (Professor of Medicine and Director, Department of Oncology, Changhai Hospital)  Enkhtsetseg Purev (Assistant Professor of Medicine, University of Colorado) The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its financial information (if available), details about CAR-T-cell based product(s), such as information on type of therapy and current development status, information on technology portfolio (if available), recent developments related to CAR-T cell immunotherapies and manufacturing capabilities of the players.  Autolus  bluebird Bio  Bristol Myers Squibb  Carsgen Therapeutics  Cellectis  Cellular Biomedicine Group  Gilead Sciences  Innovative Cellular Therapeutics  Kuur Therapeutics  Noile-Immune Biotech  Novartis  Shanghai GeneChem  Sinobioway Cell Therapy  Takara Bio  Wellington Zhaotai Therapies Get more details on the CAR-T Cell Therapy Market report https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html You may also be interested in the following titles: DNA Encoded Libraries Quantum Computing in Drug Discovery Services Market You may also like to learn what our experts are sharing in Roots educational series: mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule TIL Therapies: A New Paradigm in Cancer Treatment About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CARTcelltherapyMarket #CARTcelltherapyMarket Size #CARTcellth0erapyMarketGrowth #CARTcelltherapies #ChimericAntigenReceptor
    by jameshebrew,  Health 
    0 reply
  • peradotech4
  • Peradotech Website: https://peradotech.com/silc/ Address: 4461 Camino Real Way, Fort Myers, FL 339566 Perado Tech uses intake for immigration law firms that help identify, prioritize, and tackle important strategies in immigration law. The technology used to intake for immigration law firms provides legal firms tools and guidance to use the system and better serve their clients. Based in Fort Myers, Florida, intake for immigration law firms utilizing Perado Tech can streamline, leverage and improve client success with a competitive edge. #Legal #legal intake services
    by peradotech4,  Law & Ethics 
    0 reply
  • elysesantorohome
  • Interior Designer In Fort Myers Naples : Visit Elyse Santoro Home for the finest interior designer in Fort Myers, Naples. We produce distinctive designs that showcase your sense of fashion and personality. We make sure that your home radiates happiness, prosperity, and tranquility. For additional information, please visit our website. For more information visit us on : https://elysesantorohome.com/services-for-you
    by elysesantorohome,  Business & Finance 
    0 reply
  • elysesantorohome
  • Interior Design In Naples Fort Myers : If you want the best interior design in Naples, Fort Myers, head to Elyse Santoro Home. We create unique designs that reflect your sense of style and personality. We make sure that your house exudes joy, wealth, and tranquility. Visit our website for more details ; https://elysesantorohome.com/services-for-you
    by elysesantorohome,  Other - Business & Finance 
    0 reply
  • jameshebrew
  • CAR-T CELL THERAPIES: ADDRESSING KEY UNMET NEEDS ACROSS VARIOUS ONCOLOGICAL INDICATIONS Amidst the active initiatives undertaken to develop more targeted anti-cancer therapies, CAR-T therapies have emerged as a promising option, given their ability to eradicate tumor cells from the body with minimal treatment-related side effects. Further, CAR-T cell therapy, a relatively recent addition to the gamut of anticancer interventions, has demonstrated significant promise. Overall, this highly specific and promising form of CAR-T cell therapy treatment, which harnesses the versatile effector machinery of the human immune system, has revolutionized cancer treatment, globally. Given the consistent increase in number of cell therapies being developed and launched, this upcoming therapeutic segment is on its way to becoming one of the highest valued markets within the biopharmaceutical industry. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/269/request-sample.html At present, more than 5 CAR-T therapies have been approved for several hematological malignancies, including KYMRIAH® (Novartis), YESCARTA® (Gilead Sciences), TECARTUS™ (Gilead Sciences), Breyanzi® (Bristol Myers Squibb), Abecma™ (Bristol Myers Squibb) and CARVYKTI™ (Janssen Biotech / Legend Biotech). In fact, more than 170 companies are engaged in the development of over 970 early and late-stage CAR-T therapies, worldwide. Moreover, several promising leads are anticipated to be commercially launched over the coming decade, following which the market is projected to grow at a substantial pace. Over 6,500 patents related to CAR-T cell therapies have been recently filed / granted, demonstrating the continued innovation in this domain. In addition, more than 260 collaborations have been inked between several industry / academic stakeholders in order to advance the development of various pipeline candidates. To fund product development initiatives, capital investments worth more than USD 24 billion have been made by various private and public sector investors, in the last few years. Driven by the ongoing pace of innovation in this field, sufficient financial support from investors and encouraging clinical trial results, the CAR-T cell therapy market is likely to witness significant growth in the foreseen future. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com
    by jameshebrew,  Health 
    0 reply
  • markjoseph
  • Global Active Pharmaceutical Ingredients Market Outlook, 2027 Is Anticipated To Grow At A Annual Of More Than 6.4% Form 2021 to 2027. The Industry insights of the report Global Active Pharmaceutical Ingredients Market Outlook, 2027helps with the successful launch of a new product. This market report efficiently collects, analyzes, and evaluates information about a product or service to be offered for sale in that market. This market research report makes it easy to attain customer demographics which forms the core of any business. This report studies Potential clients for the product or service and their characteristics, spending habits, location, and needs of its target market. According to the report title “Global Active Pharmaceutical Ingredients Market Outlook, 2027”, published by Bonafide Research, The global active pharmaceutical ingredients market size was valued at USD 187.2 billion in 2020 and is expected to expand at a CAGR of more than 6.8% from 2021 to 2027. API is used widely in various therapeutic applications like oncology, CVD, respiratory disease, infectious disease, diabetes & pain management, etc. The oncology segment is expected to grow with the highest CAGR of 8.4% because of the emerging demand of High Potent APIs for cancer treatment. Although, cardiovascular disease covers huge market shares in terms of value. The market is divided into two segments by the API type, i.e., branded & generic APIs. The branded API dominated the market share in 2020. Due to the expiration of branded drug patents, the generic APIs segment is expected to grow rapidly during the forecast period. Also, unmet clinical needs in developing countries increased acceptance of OTC drugs, and lower generic drug costs drive the generic segment. The generic API contains the same chemical substance but differs in taste, color, packaging process, or manufacturing ingredients. Get Access to Report Sample @ https://www.bonafideresearch.com/samplereport/220379971/global-active-pharmaceutical-ingredients-market The market is highly competitive, with a considerable number of regional and global players. At the same time, this report includes company profiling for the companies like Major Companies present in the market: Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Limited, Lupin Limited, Sun Pharmaceutical Industries Limited, Pfizer Inc., Novartis International AG, Biocon Limited, Sanofi S.A., Teva Pharmaceutical Industries Limited, AbbVie Inc., GlaxoSmithKline plc., Merck & Co., Inc., Viatris Inc., Bristol-Myers Squibb Company Aspects covered in this report • Global Active Pharmaceutical Ingredients Market with its value and forecast along with its segments • Region & country wise Active Pharmaceutical Ingredients market analysis • Application wise Active Pharmaceutical Ingredients distribution • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation Owning our reports will help you solve the following issues: 1. What is the market size and forecast of the Global Active Pharmaceutical Ingredients Market Outlook, 2027? Our research and insights help our clients to foresee upcoming market size and forecast. 2. What are the inhibiting factors and impact of COVID-19 shaping Global Active Pharmaceutical Ingredients Market Outlook, 2027 during the forecast period? Our research and analysis help our clients to see how COVID-19 has Impacted the industry. This allows our clients to invest or divest their resources. 3. Which region outstands in the Global Active Pharmaceutical Ingredients Market Outlook, 2027? Our research helps our clients to see which the dominating region in the market is, with supporting trends and developments. 4. Which are the segments to invest in over the forecast period in Global Active Pharmaceutical Ingredients Market Outlook, 2027? Our research report allows the company/ investor to identify the most promising product segment, which is to have more potential in the coming years. 5. What is the competitive strategic window for opportunities in the Global Active Pharmaceutical Ingredients Market Outlook, 2027? Through an intensive primary study, we have identified the trends and development that can be expected in the forecasted period, along with the change in the preference of the consumers. 6. What are the technology trends and regulatory frameworks in the Global Active Pharmaceutical Ingredients Market Outlook, 2027? Our research report covers, the laws, rules and regulations and other mandatory legal procedures the marketers needs to abide by. 7. What are the major companies in the Global Active Pharmaceutical Ingredients Market Outlook, 2027? Our market research report covers the detailed profiling of the leading companies in the industry, and also a brief discussion about the smaller emerging brands. COVID-19 Impact: As the Covid-19 pandemic had resulted into strict lockdown and shut down of many companies majorly in Asia-Pacific impacted global active pharmaceutical ingredients. The y-o-y growth in global APIs market was not met in 2020 as the lack of raw material supply chain & labor. Although the demand for the drugs likes paracetamol, azithromycin and hydroxychloroquine is up taking the charge. To treat the symptoms and numerous health conditions that a COVID-19 patient may have, such as cough, cold & high fever, a variety of medications are employed, leading to the pharmaceutical industry being the epicenter of the pandemic. An excellent Global Active Pharmaceutical Ingredients Market Outlook, 2027 document has the best market research offerings and the required critical information, whether it is about looking for new product trends or competitive analysis of an existing or emerging market. With this business report, companies can sharpen their competitive edge again and again. The market report has expert insights on global industries, products, company profiles, and market trends. Types of Technology in the report: • Solar Photovoltaic • Concentrated Solar Power (CSP) Based on synthesis of Active Pharmaceutical Ingredients in the report: • Synthetic APIs • Biotech APIs Based on drug type of Active Pharmaceutical Ingredients in the report: • Branded APIs • Generic APIs Table of Contents Covered In This Global Active Pharmaceutical Ingredients Market Report: Table of Contents 1. Executive Summary 2. Report Methodology 3. Market Structure 3.1. Market Considerate 3.2. Market Definition 4. Economic /Demographic Snapshot 5. Top 10 Pharmaceutical Markets Worldwide, 2020 To Be Continue… To access the full report visit here@ https://www.bonafideresearch.com/product/220379971/global-active-pharmaceutical-ingredients-market# Actual Market Research India Bulls Mega Mall, Jetalpur Road, Vadodara sales@actualmarketresearch.com North America: +1 201 793 8545 Asia-Pacific: +91 7878231309 https://www.actualmarketresearch.com/ Actual Market Research is a distinctive and contemporary market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. We endeavor to provide appropriate solutions to complex business challenges and initiate an effortless decision-making process
    by markjoseph,  Business & Finance 
    0 reply
1 2 Next Last